IRCT20171021036903N2
Recruiting
Phase 1
phase I clinical trial placental mesenchymal stem cell therapy for the treatment of type 1 diabetes mellitus
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •both gender
- •12\-18 years old
- •type one diabetes mellitus
- •at least one positive auto antibody of T1DM
- •in first 6 month of diagnosis
Exclusion Criteria
- •simultaneous auto immune disorders
- •chronic disorder other than diabetes
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 1
Mesenchymal stem cells-derived exosomes in severe refractory inflammatory bowel disease patientsIRCT20230801058996N5Shahid Beheshti University of Medical Sciences12
Recruiting
Phase 1
Safety of injection of placental mesenchymal stem cell derived exosomes for Treatment of resistant perianal fistula in Crohn's patientsCrohn Patients with fistula.Crohn's disease of small intestine with fistulaK50.013IRCT20200413047063N3Omid cell and tissue Company20
Completed
Phase 2
Perinatal Tissue Mesenchyme Stem Cells in the Treatment for Caesarean Section ScarsCicatrixNCT02772289Maternal and Child Health Hospital of Foshan90
Completed
Not Applicable
Clinical trial of mesenchymal stem cell mobilization factor KOI2 in epidermolysis bullosa patientsJPRN-UMIN000029962Osaka University Hospital9
Recruiting
Phase 1
Placental Mesenchymal Stem Cell Therapy for Acute Respiratory Distress Syndrome in Coronavirus Infection: A Phase 1-2 Clinical TrialAcute Respiratory Distress Syndrome of COVID-19.COVID-19U07.1IRCT20200413047063N1Execution of Imam Khomeini's Order20